US Patent 10954229 GPR119 agonist compounds
Patent 10954229 was granted and assigned to Mankind Pharma Ltd on March, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+159 characters)
Article
Patent abstract
The present invention relates to novel compounds of formula (I), process for preparation of the same and composition comprising these compounds.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Amol Pandurang Gunjal0
Anil Kumar0
Himanshu Rai0
Jeevan Verma0
Puneet Kumar0
Rakesh Ishwar Patil0
Santosh Kumar Rai0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109542290
Date of Patent
March 23, 2021
0Patent Application Number
169095430
Date Filed
June 23, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10954229 GPR119 agonist compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10954229
Date of patent
March 23, 2021
Patent application number
16909543
Date Filed
June 23, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 10954229 GPR119 agonist compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.